Biobanking Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global biobanking market size reached US$ 53.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 77.6 Billion by 2027, exhibiting a growth rate (CAGR) of 6.18% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Biobanking refers to the process of analyzing and storing information of human biospecimens, which are collected from healthy volunteers or people with a particular condition. This information is used in research and academic studies to improve the understanding of health and different diseases. Presently, modern biobanks have large-scale analysis of specific disease biomarkers, which include biological or digital material with well-annotated clinical and biological data. They provide a basis for improving personalized medical approaches wherein effective biomarker identification is crucial for disease diagnosis and prognosis.
Biobanking Market Trends:
Biobanking nowadays is gaining widespread adoption in collecting high-quality and well-annotated human biospecimens, understanding the pathogenic mechanisms, and identifying therapeutic targets of coronavirus disease (COVID-19). Apart from this, due to the increasing prevalence of new infectious and chronic diseases, there is a rise in the demand for biobanking to develop diagnostics that can accurately and quickly identify pathogens. This can also be accredited to the growing aging population, in confluence with the escalating demand for regenerative medicine and personalized treatment across the globe. Moreover, developments in genomics, metagenomics, proteomics, disease biology, bioenergy, environmental remediation, and allied fields are contributing to the market growth. Besides this, health agencies of numerous countries are investing in virtual biobank network models that offer a faster and sustainable solution. These network models offer electronic databases that help investigators to locate biospecimens and data mining from multiple biobanks. Furthermore, leading market players are offering a diverse portfolio of biobanking products and services that enable sharing of insights and critical information to advancing science. These innovations are projected to strengthen the growth of the market in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global biobanking market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on specimen type, biobank type, application and end user.
Breakup by Specimen Type:
Blood Products
Solid Tissue
Cell Lines
Nucleic Acid
Others
Breakup by Biobank Type:
Population-based Biobanks
Disease-oriented Biobanks
Breakup by Application:
Therapeutics
Research
Breakup by End User:
Academic Institutions
Pharma and Biotech Companies
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Brooks Automation Inc., Bay Biosciences LLC, Boca Biolistics, Ctibiotech, Cureline Inc., Firalis, Greiner Bio-One International GmbH, Hamilton Company, Merck KGaA, ProteoGenex Inc., Thermo Fisher Scientific Inc. and VWR Corporation (Avantor Inc.).
Key Questions Answered in This Report
1. What was the size of the global biobanking market in 2021?
2. What is the expected growth rate of the global biobanking market during 2022-2027?
3. What are the key factors driving the global biobanking market?
4. What has been the impact of COVID-19 on the global biobanking market?
5. What is the breakup of the global biobanking market based on the specimen type?
6. What is the breakup of the global biobanking market based on the biobank type?
7. What is the breakup of the global biobanking market based on the application?
8. What is the breakup of the global biobanking market based on the end user?
9. What are the key regions in the global biobanking market?
10. Who are the key players/companies in the global biobanking market?
Biobanking refers to the process of analyzing and storing information of human biospecimens, which are collected from healthy volunteers or people with a particular condition. This information is used in research and academic studies to improve the understanding of health and different diseases. Presently, modern biobanks have large-scale analysis of specific disease biomarkers, which include biological or digital material with well-annotated clinical and biological data. They provide a basis for improving personalized medical approaches wherein effective biomarker identification is crucial for disease diagnosis and prognosis.
Biobanking Market Trends:
Biobanking nowadays is gaining widespread adoption in collecting high-quality and well-annotated human biospecimens, understanding the pathogenic mechanisms, and identifying therapeutic targets of coronavirus disease (COVID-19). Apart from this, due to the increasing prevalence of new infectious and chronic diseases, there is a rise in the demand for biobanking to develop diagnostics that can accurately and quickly identify pathogens. This can also be accredited to the growing aging population, in confluence with the escalating demand for regenerative medicine and personalized treatment across the globe. Moreover, developments in genomics, metagenomics, proteomics, disease biology, bioenergy, environmental remediation, and allied fields are contributing to the market growth. Besides this, health agencies of numerous countries are investing in virtual biobank network models that offer a faster and sustainable solution. These network models offer electronic databases that help investigators to locate biospecimens and data mining from multiple biobanks. Furthermore, leading market players are offering a diverse portfolio of biobanking products and services that enable sharing of insights and critical information to advancing science. These innovations are projected to strengthen the growth of the market in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global biobanking market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on specimen type, biobank type, application and end user.
Breakup by Specimen Type:
Blood Products
Solid Tissue
Cell Lines
Nucleic Acid
Others
Breakup by Biobank Type:
Population-based Biobanks
Disease-oriented Biobanks
Breakup by Application:
Therapeutics
Research
Breakup by End User:
Academic Institutions
Pharma and Biotech Companies
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Brooks Automation Inc., Bay Biosciences LLC, Boca Biolistics, Ctibiotech, Cureline Inc., Firalis, Greiner Bio-One International GmbH, Hamilton Company, Merck KGaA, ProteoGenex Inc., Thermo Fisher Scientific Inc. and VWR Corporation (Avantor Inc.).
Key Questions Answered in This Report
1. What was the size of the global biobanking market in 2021?
2. What is the expected growth rate of the global biobanking market during 2022-2027?
3. What are the key factors driving the global biobanking market?
4. What has been the impact of COVID-19 on the global biobanking market?
5. What is the breakup of the global biobanking market based on the specimen type?
6. What is the breakup of the global biobanking market based on the biobank type?
7. What is the breakup of the global biobanking market based on the application?
8. What is the breakup of the global biobanking market based on the end user?
9. What are the key regions in the global biobanking market?
10. Who are the key players/companies in the global biobanking market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL BIOBANKING MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY SPECIMEN TYPE
6.1 Blood Products
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Solid Tissue
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Cell Lines
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Nucleic Acid
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY BIOBANK TYPE
7.1 Population-based Biobanks
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Disease-oriented Biobanks
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Therapeutics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Research
8.2.1 Market Trends
8.2.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Academic Institutions
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Pharma and Biotech Companies
9.2.1 Market Trends
9.2.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Brooks Automation Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.2 Bay Biosciences LLC
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Boca Biolistics
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Ctibiotech
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Cureline Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Firalis
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Greiner Bio-One International GmbH
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Hamilton Company
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Merck KGaA
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 ProteoGenex Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Thermo Fisher Scientific Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 VWR Corporation (Avantor Inc.)
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL BIOBANKING MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY SPECIMEN TYPE
6.1 Blood Products
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Solid Tissue
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Cell Lines
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Nucleic Acid
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY BIOBANK TYPE
7.1 Population-based Biobanks
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Disease-oriented Biobanks
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Therapeutics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Research
8.2.1 Market Trends
8.2.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Academic Institutions
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Pharma and Biotech Companies
9.2.1 Market Trends
9.2.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Brooks Automation Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.2 Bay Biosciences LLC
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Boca Biolistics
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Ctibiotech
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Cureline Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Firalis
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Greiner Bio-One International GmbH
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Hamilton Company
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Merck KGaA
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 ProteoGenex Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Thermo Fisher Scientific Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 VWR Corporation (Avantor Inc.)
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
LIST OF TABLES
Table 1: Global: Biobanking Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Biobanking Market Forecast: Breakup by Specimen Type (in Million US$), 2022-2027
Table 3: Global: Biobanking Market Forecast: Breakup by Biobank Type (in Million US$), 2022-2027
Table 4: Global: Biobanking Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Biobanking Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Biobanking Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Biobanking Market: Competitive Structure
Table 8: Global: Biobanking Market: Key Players
Table 1: Global: Biobanking Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Biobanking Market Forecast: Breakup by Specimen Type (in Million US$), 2022-2027
Table 3: Global: Biobanking Market Forecast: Breakup by Biobank Type (in Million US$), 2022-2027
Table 4: Global: Biobanking Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Biobanking Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Biobanking Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Biobanking Market: Competitive Structure
Table 8: Global: Biobanking Market: Key Players
LIST OF FIGURES
Figure 1: Global: Biobanking Market: Major Drivers and Challenges
Figure 2: Global: Biobanking Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Biobanking Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Biobanking Market: Breakup by Specimen Type (in %), 2021
Figure 5: Global: Biobanking Market: Breakup by Biobank Type (in %), 2021
Figure 6: Global: Biobanking Market: Breakup by Application (in %), 2021
Figure 7: Global: Biobanking Market: Breakup by End User (in %), 2021
Figure 8: Global: Biobanking Market: Breakup by Region (in %), 2021
Figure 9: Global: Biobanking (Blood Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Biobanking (Blood Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Biobanking (Solid Tissue) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Biobanking (Solid Tissue) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Biobanking (Cell Lines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Biobanking (Cell Lines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Biobanking (Nucleic Acid) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Biobanking (Nucleic Acid) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Biobanking (Other Specimen Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Biobanking (Other Specimen Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Biobanking (Population-based Biobanks) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Biobanking (Population-based Biobanks) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Biobanking (Disease-oriented Biobanks) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Biobanking (Disease-oriented Biobanks) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Biobanking (Therapeutics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Biobanking (Therapeutics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Biobanking (Research) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Biobanking (Research) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Biobanking (Academic Institutions) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Biobanking (Academic Institutions) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Biobanking (Pharma and Biotech Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Biobanking (Pharma and Biotech Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: North America: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: North America: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: United States: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: United States: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Canada: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Canada: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Asia-Pacific: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Asia-Pacific: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: China: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: China: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Japan: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Japan: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: India: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: India: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: South Korea: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: South Korea: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Australia: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Australia: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Indonesia: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Indonesia: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Others: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Europe: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Europe: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Germany: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Germany: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: France: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: France: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: United Kingdom: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: United Kingdom: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Italy: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Italy: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Spain: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Spain: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Russia: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Russia: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Others: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Latin America: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Latin America: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Brazil: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Brazil: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Mexico: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Mexico: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Middle East and Africa: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Middle East and Africa: Biobanking Market: Breakup by Country (in %), 2021
Figure 79: Middle East and Africa: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Global: Biobanking Industry: SWOT Analysis
Figure 81: Global: Biobanking Industry: Value Chain Analysis
Figure 82: Global: Biobanking Industry: Porter's Five Forces Analysis
Figure 1: Global: Biobanking Market: Major Drivers and Challenges
Figure 2: Global: Biobanking Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Biobanking Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Biobanking Market: Breakup by Specimen Type (in %), 2021
Figure 5: Global: Biobanking Market: Breakup by Biobank Type (in %), 2021
Figure 6: Global: Biobanking Market: Breakup by Application (in %), 2021
Figure 7: Global: Biobanking Market: Breakup by End User (in %), 2021
Figure 8: Global: Biobanking Market: Breakup by Region (in %), 2021
Figure 9: Global: Biobanking (Blood Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Biobanking (Blood Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Biobanking (Solid Tissue) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Biobanking (Solid Tissue) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Biobanking (Cell Lines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Biobanking (Cell Lines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Biobanking (Nucleic Acid) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Biobanking (Nucleic Acid) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Biobanking (Other Specimen Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Biobanking (Other Specimen Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Biobanking (Population-based Biobanks) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Biobanking (Population-based Biobanks) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Biobanking (Disease-oriented Biobanks) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Biobanking (Disease-oriented Biobanks) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Biobanking (Therapeutics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Biobanking (Therapeutics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Biobanking (Research) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Biobanking (Research) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Biobanking (Academic Institutions) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Biobanking (Academic Institutions) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Biobanking (Pharma and Biotech Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Biobanking (Pharma and Biotech Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: North America: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: North America: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: United States: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: United States: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Canada: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Canada: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Asia-Pacific: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Asia-Pacific: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: China: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: China: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Japan: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Japan: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: India: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: India: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: South Korea: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: South Korea: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Australia: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Australia: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Indonesia: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Indonesia: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Others: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Europe: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Europe: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Germany: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Germany: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: France: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: France: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: United Kingdom: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: United Kingdom: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Italy: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Italy: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Spain: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Spain: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Russia: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Russia: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Others: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Latin America: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Latin America: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Brazil: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Brazil: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Mexico: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Mexico: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Middle East and Africa: Biobanking Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Middle East and Africa: Biobanking Market: Breakup by Country (in %), 2021
Figure 79: Middle East and Africa: Biobanking Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Global: Biobanking Industry: SWOT Analysis
Figure 81: Global: Biobanking Industry: Value Chain Analysis
Figure 82: Global: Biobanking Industry: Porter's Five Forces Analysis
